Application YC di Isabl

Winter 2020Active

Isabl ha partecipato a Y Combinator nel batch Winter 2020 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Winter 2020
Settore: HealthcareDiagnostics
Dimensione team: 5
Stato: Active
Lanciata: 2022

Founder

Juan MedinaFounder
Andrew KungFounder
Elli PapaemmanuilFounder

Cosa fa Isabl

Isabl has developed software that can analyze the entire genome of cancer patients. Today, when people get cancer, they get a genetic test of their tumor that analyzes only a few possible mutations. With Isabl, you run the tumor through an Illumina sequencer and get the whole genome, then our software is able to analyze all the mutations. Our breakthrough technology provides unprecedented clarity into tumor biology to aid treatment planning. This opens up opportunities for precision diagnostics, disease surveillance and biomarker discovery.

Application YC di Isabl, ricostruita

Domanda per Y Combinator

Isabl, batch Winter 2020. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Isabl

Describe what your company does in 50 characters or less.

Cancer tests using whole genome and transcriptome data

What is your company going to make? Please describe your product and what it does or will do.

We built software that analyzes the complete genome and transcriptome data from cancer tumors sequenced on Illumina machines. Instead of limiting to a few genes, our product processes whole genome sequences to identify all relevant mutations and changes. This deeper insight helps oncologists plan treatment better and supports diagnostics and biomarker discovery.

Where do you live now, and where would the company be based after YC?

We live in New York, NY, and the company is currently based here, with some team members remote. It would remain here after YC.

Explain your decision regarding location.

We chose New York because of its proximity to top medical centers, cancer researchers, and hospitals who are our early users and key collaborators. It's important to be close to where the genome sequencing gets done and analyzed.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di Isabl?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Isabl (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Isabl si presenterebbe a YC, non il testo che hanno inviato.